Related Experiment Videos
SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task
Mary C Wolff1, J David Leander
1Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Mail Code No. 0510, Indianapolis, IN 46285, USA. wolff_mary_c@lilly.com
European Journal of Pharmacology
|October 3, 2003
Summary
A cannabinoid CB(1) receptor antagonist, SR141716A, improved memory consolidation in rats tested after a long delay. This suggests potential therapeutic uses for memory disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Psychology
Background:
- The endogenous cannabinoid system influences memory processes.
- Cannabinoid CB(1) receptors are implicated in cognitive functions.
- Understanding the role of CB(1) antagonism in memory is crucial.
Purpose of the Study:
- To investigate the effects of SR141716A, a selective CB(1) receptor antagonist, on memory consolidation.
- To determine if SR141716A can modulate memory performance in a radial maze task.
- To explore the potential of CB(1) receptor antagonists in treating memory impairments.
Main Methods:
- Utilized an eight-arm radial maze task with well-trained rats.
- Administered SR141716A intraperitoneally after the information phase.
- Assessed memory recall after short (3 h) and long (7 h) delay periods.
Main Results:
- SR141716A did not affect memory errors after a short delay.
- SR141716A significantly reduced memory errors after a long delay (7 h).
- The drug demonstrated a beneficial effect on memory consolidation.
Conclusions:
- Cannabinoid CB(1) receptor antagonism can enhance memory consolidation processes.
- SR141716A shows potential as a therapeutic agent for memory disorders.
- Targeting the cannabinoid system may offer novel strategies for cognitive enhancement.